Barclays
NEUE

Barclays’s NeueHealth NEUE Stock Holding History

Barclays’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$21 – 5523
2024
Q3 		$21 Buy
+4
New +$21 ﹤0.01% 5232
2024
Q1 		– Sell
-70
Closed -$534 – 5420
2023
Q4 		$534 Buy
+70
New +$470 ﹤0.01% 5132
2023
Q2 		– Sell
-1,220
Closed -$21.5K – 5157
2023
Q1 		$21.5K Buy
1,220
+572
+88% +$29.5K ﹤0.01% 4645
2022
Q4 		$33.7K Buy
648
+546
+535% +$39.7K ﹤0.01% 4679
2022
Q3 		$9K Sell
102
-19
-16% -$2.52K ﹤0.01% 4367
2022
Q2 		$18K Sell
121
-404
-77% -$58.8K ﹤0.01% 4450
2022
Q1 		$81K Buy
+525
New +$117K ﹤0.01% 3886

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Barclays's NEUE Position: Q4 2024 in Review

Barclays sold out of NeueHealth (NEUE) in Q4 2024, closing a stake of 4 shares — an estimated $21 sold.

Barclays first reported a position in NEUE in Q1 2022 and held it in 7 quarters. The position peaked at $81K in Q1 2022. 38 funds tracked by Wall St. Rank hold NEUE as of Q4 2024.

  • Barclays reported no remaining NeueHealth position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 4 NeueHealth shares in Q4 2024, an estimated $21.
  • Barclays first reported a position in NeueHealth in Q1 2022 and held it in 7 quarters.
  • Barclays's NeueHealth position peaked at $81K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held NeueHealth as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.